Antibiotic resistance is on the rise, imposing enormous costs on society and spurring concerns about the treatment of infectious diseases. The problem can be traced to the widespread overuse of readily available drugs. Policymakers should consider creating economic incentives to encourage individuals and drug manufacturers to take into account the societal costs of using antibiotics.